Vital Therapies, Inc. Email Format

BiotechnologyNew York, United States11-50 Employees

Immunic, Inc., formerly Vital Therapies, Inc., is a biotechnology company based in New York City that pursues late-stage development of oral therapies for neurologic diseases. Its program focus includes multiple sclerosis, with a Phase 3 program and Phase 2 data highlighted in industry updates. The company trades on the Nasdaq under the ticker IMUX. In 2026 it announced leadership changes, appointing Erik Lundgren as Chief Executive Officer effective June 1. With a relatively small to mid-sized workforce, Immunic operates in the biotechnology research sector from its New York base.

Sign up for free to view info

Company overview Employee directory